Financial Services
Compare Stocks
4 / 10Stock Comparison
VACHU vs GS vs MS vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Capital Markets
Financial - Capital Markets
Banks - Diversified
VACHU vs GS vs MS vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Financial Services | Financial - Capital Markets | Financial - Capital Markets | Banks - Diversified |
| Market Cap | $551M | $322.67B | $337.20B | $842.21B |
| Revenue (TTM) | $0.00 | $126.85B | $103.14B | $270.79B |
| Net Income (TTM) | $7M | $16.67B | $16.18B | $58.03B |
| Gross Margin | — | 41.1% | 55.6% | 58.6% |
| Operating Margin | — | 14.5% | 17.1% | 27.7% |
| Forward P/E | 46.7x | 17.5x | 17.8x | 14.0x |
| Total Debt | $0.00 | $616.93B | $360.49B | $751.15B |
| Cash & Equiv. | $182K | $182.09B | $75.74B | $469.32B |
VACHU vs GS vs MS vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 24 | Jun 26 | Return |
|---|---|---|---|
| Voyager Acquisition… (VACHU) | 100 | 168.3 | +68.3% |
| The Goldman Sachs G… (GS) | 100 | 203.6 | +103.6% |
| Morgan Stanley (MS) | 100 | 204.5 | +104.5% |
| JPMorgan Chase & Co. (JPM) | 100 | 139.0 | +39.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VACHU vs GS vs MS vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VACHU is the clearest fit if your priority is bank quality.
- NIM 4.0% vs GS's 0.5%
- 130.0% NII/revenue growth vs JPM's 14.6%
GS carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 17.0%, EPS growth 77.3%
- Efficiency ratio 0.3% vs MS's 0.4% (lower = leaner)
- +74.2% vs JPM's +21.5%
- Efficiency ratio 0.3% vs MS's 0.4%
MS is the clearest fit if your priority is long-term compounding and defensive.
- 7.9% 10Y total return vs GS's 6.1%
- Beta 1.39, yield 1.8%, current ratio 0.66x
- 1.8% yield, 12-year raise streak, vs JPM's 1.6%, (1 stock pays no dividend)
JPM is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 15 yrs, beta 0.95, yield 1.6%
- Lower volatility, beta 0.95, current ratio 0.65x
- PEG 1.08 vs MS's 2.00
- Lower P/E (14.0x vs 17.8x), PEG 1.08 vs 2.00
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 130.0% NII/revenue growth vs JPM's 14.6% | |
| Value | Lower P/E (14.0x vs 17.8x), PEG 1.08 vs 2.00 | |
| Quality / Margins | Efficiency ratio 0.3% vs MS's 0.4% (lower = leaner) | |
| Stability / Safety | Beta 0.95 vs GS's 1.57, lower leverage | |
| Dividends | 1.8% yield, 12-year raise streak, vs JPM's 1.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +74.2% vs JPM's +21.5% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs MS's 0.4% |
VACHU vs GS vs MS vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
VACHU vs GS vs MS vs JPM — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 3 of 6 categories
GS leads 1 • VACHU leads 0 • MS leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM and VACHU operate at a comparable scale, with $270.8B and $0 in trailing revenue. JPM is the more profitable business, keeping 21.6% of every revenue dollar as net income compared to GS's 11.3%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $126.9B | $103.1B | $270.8B |
| EBITDAEarnings before interest/tax | -$4M | $23.4B | $26.3B | $81.3B |
| Net IncomeAfter-tax profit | $7M | $16.7B | $16.2B | $58.0B |
| Free Cash FlowCash after capex | -$412,702 | $15.8B | -$6.7B | -$119.7B |
| Gross MarginGross profit ÷ Revenue | — | +41.1% | +55.6% | +58.6% |
| Operating MarginEBIT ÷ Revenue | — | +14.5% | +17.1% | +27.7% |
| Net MarginNet income ÷ Revenue | — | +11.3% | +13.0% | +21.6% |
| FCF MarginFCF ÷ Revenue | — | -12.1% | -2.0% | -15.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -96.4% | +45.8% | +48.9% | +16.0% |
Valuation Metrics
JPM leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
At 15.8x trailing earnings, JPM trades at a 66% valuation discount to VACHU's 46.7x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 1.22x vs MS's 2.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $551M | $322.7B | $337.2B | $842.2B |
| Enterprise ValueMkt cap + debt − cash | $551M | $757.5B | $621.9B | $1.12T |
| Trailing P/EPrice ÷ TTM EPS | 46.67x | 25.62x | 26.66x | 15.82x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 17.52x | 17.83x | 14.03x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.83x | 2.99x | 1.22x |
| EV / EBITDAEnterprise value multiple | — | 36.44x | 27.33x | 13.54x |
| Price / SalesMarket cap ÷ Revenue | — | 2.54x | 3.27x | 3.11x |
| Price / BookPrice ÷ Book value/share | 1.66x | 2.84x | 3.24x | 2.61x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — |
Profitability & Efficiency
JPM leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 16.1% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $6 for VACHU. JPM carries lower financial leverage with a 2.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to GS's 5.06x. On the Piotroski fundamental quality scale (0–9), MS scores 5/9 vs VACHU's 2/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +5.6% | +12.6% | +14.6% | +16.1% |
| ROA (TTM)Return on assets | +2.5% | +0.9% | +1.2% | +1.3% |
| ROICReturn on invested capital | -0.5% | +1.9% | +2.9% | +5.4% |
| ROCEReturn on capital employed | -0.7% | +3.6% | +3.8% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 5 | 5 |
| Debt / EquityFinancial leverage | — | 5.06x | 3.42x | 2.18x |
| Net DebtTotal debt minus cash | -$182,103 | $434.8B | $284.7B | $281.8B |
| Cash & Equiv.Liquid assets | $182,103 | $182.1B | $75.7B | $469.3B |
| Total DebtShort + long-term debt | $0 | $616.9B | $360.5B | $751.1B |
| Interest CoverageEBIT ÷ Interest expense | — | 0.31x | 0.44x | 0.74x |
Total Returns (Dividends Reinvested)
GS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GS five years ago would be worth $28,253 today (with dividends reinvested), compared to $16,800 for VACHU. Over the past 12 months, GS leads with a +74.2% total return vs JPM's +21.5%. The 3-year compound annual growth rate (CAGR) favors GS at 49.7% vs VACHU's 18.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +57.2% | +14.6% | +17.6% | -3.1% |
| 1-Year ReturnPast 12 months | +61.7% | +74.2% | +65.3% | +21.5% |
| 3-Year ReturnCumulative with dividends | +68.0% | +235.2% | +166.3% | +135.5% |
| 5-Year ReturnCumulative with dividends | +68.0% | +182.5% | +145.6% | +102.5% |
| 10-Year ReturnCumulative with dividends | +68.0% | +610.4% | +790.1% | +435.6% |
| CAGR (3Y)Annualised 3-year return | +18.9% | +49.7% | +38.6% | +33.0% |
Risk & Volatility
Evenly matched — VACHU and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
VACHU is the less volatile stock with a -1.88 beta — it tends to amplify market swings less than GS's 1.57 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 96.7% from its 52-week high vs VACHU's 83.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -1.88x | 1.57x | 1.39x | 0.95x |
| 52-Week HighHighest price in past year | $20.10 | $1095.89 | $219.16 | $337.25 |
| 52-Week LowLowest price in past year | $10.30 | $592.90 | $127.34 | $260.31 |
| % of 52W HighCurrent price vs 52-week peak | +83.6% | +94.8% | +96.7% | +92.6% |
| RSI (14)Momentum oscillator 0–100 | 51.4 | 74.9 | 74.9 | 58.4 |
| Avg Volume (50D)Average daily shares traded | 1K | 1.9M | 4.5M | 7.1M |
Analyst Outlook
Evenly matched — MS and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: GS as "Hold", MS as "Buy", JPM as "Buy". Consensus price targets imply 8.5% upside for JPM (target: $339) vs -5.6% for GS (target: $981). For income investors, MS offers the higher dividend yield at 1.80% vs GS's 1.30%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | — | $980.78 | $203.00 | $338.78 |
| # AnalystsCovering analysts | — | 55 | 52 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | +1.3% | +1.8% | +1.6% |
| Dividend StreakConsecutive years of raises | — | 14 | 12 | 15 |
| Dividend / ShareAnnual DPS | — | $13.48 | $3.81 | $5.13 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.2% | +1.2% | +3.4% |
JPM leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). GS leads in 1 (Total Returns). 2 tied.
VACHU vs GS vs MS vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VACHU or GS or MS or JPM a better buy right now?
For growth investors, The Goldman Sachs Group, Inc.
(GS) is the stronger pick with 17. 0% revenue growth year-over-year, versus 14. 6% for JPMorgan Chase & Co. (JPM). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 8x trailing P/E (14. 0x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VACHU or GS or MS or JPM?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 15. 8x versus Voyager Acquisition Corp Unit at 46. 7x. On forward P/E, JPMorgan Chase & Co. is actually cheaper at 14. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 1. 08x versus Morgan Stanley's 2. 00x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — VACHU or GS or MS or JPM?
Over the past 5 years, The Goldman Sachs Group, Inc.
(GS) delivered a total return of +182. 5%, compared to +68. 0% for Voyager Acquisition Corp Unit (VACHU). Over 10 years, the gap is even starker: MS returned +790. 1% versus VACHU's +68. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VACHU or GS or MS or JPM?
By beta (market sensitivity over 5 years), Voyager Acquisition Corp Unit (VACHU) is the lower-risk stock at -1.
88β versus The Goldman Sachs Group, Inc. 's 1. 57β — meaning GS is approximately -184% more volatile than VACHU relative to the S&P 500. On balance sheet safety, JPMorgan Chase & Co. (JPM) carries a lower debt/equity ratio of 2% versus 5% for The Goldman Sachs Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VACHU or GS or MS or JPM?
By revenue growth (latest reported year), The Goldman Sachs Group, Inc.
(GS) is pulling ahead at 17. 0% versus 14. 6% for JPMorgan Chase & Co. (JPM). On earnings-per-share growth, the picture is similar: The Goldman Sachs Group, Inc. grew EPS 77. 3% year-over-year, compared to 21. 7% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VACHU or GS or MS or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 21. 6% net margin versus 0. 0% for Voyager Acquisition Corp Unit — meaning it keeps 21. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 27. 7% versus 0. 0% for VACHU. At the gross margin level — before operating expenses — JPM leads at 58. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VACHU or GS or MS or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 1. 08x versus Morgan Stanley's 2. 00x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, JPMorgan Chase & Co. (JPM) trades at 14. 0x forward P/E versus 17. 8x for Morgan Stanley — 3. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 8. 5% to $338. 78.
08Which pays a better dividend — VACHU or GS or MS or JPM?
In this comparison, MS (1.
8% yield), JPM (1. 6% yield), GS (1. 3% yield) pay a dividend. VACHU does not pay a meaningful dividend and should not be held primarily for income.
09Is VACHU or GS or MS or JPM better for a retirement portfolio?
For long-horizon retirement investors, Voyager Acquisition Corp Unit (VACHU) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -1.
88)). The Goldman Sachs Group, Inc. (GS) carries a higher beta of 1. 57 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VACHU: +68. 0%, GS: +610. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VACHU and GS and MS and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VACHU is a small-cap quality compounder stock; GS is a large-cap high-growth stock; MS is a large-cap high-growth stock; JPM is a large-cap deep-value stock. GS, MS, JPM pay a dividend while VACHU does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.